Genvor Restores Trading Status and Expands Global Collaborative Research Network
Woodland, CA, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Genvor, Inc. (OTCID: GNVR), a pioneer in AI-accelerated peptide technology for sustainable...
Antimicrobial
Reolite Secures Historic U.S. EPA Registration and Earns Recognition from MIT Lincoln Laboratory, Paving the Way for Entry into $2.7 Trillion Apparel and Plastics Markets
LOS ANGELES, Oct. 6, 2025 /PRNewswire/ -- Robin K. International Inc. (DBA Reolite, Chairman Billy Kang), headquartered in Los Angeles,...
Nutromics unveils world-first real-time in vivo multiplexing data at IATDMCT
MELBOURNE, Australia, Oct. 2, 2025 /PRNewswire/ -- Diagnostics company Nutromics has presented the world's first real-time, continuous data on two...
Sanara MedTech to Report Third Quarter 2025 Financial Results on November 12, 2025
FORT WORTH, TX, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical...
AUA Guidelines Recognize NGS in Recurrent UTI Care, Signaling Progress
NGS use is validated in 2025 American Urological Association guideline update, marking an important step towards more accurate and rapid...
CorMedix Announces Completion of Enrollment in Phase III ReSPECT Clinical Trial for REZZAYO
- Enrollment Completed in Ongoing Phase III ReSPECT Study in Prophylaxis of Fungal Infections in Adult Patients Undergoing Allogeneic Blood...
Basilea awarded BARDA contract for the development of novel oral phase 3-ready antibiotic ceftibuten-ledaborbactam
- Total non-dilutive funding of up to USD 159 million upon completion of predefined milestones, including near-term committed funding of...
Vanderbilt Report: Full Alliance Group helps Power Hypochlorous Acid’s Breakout from Hospitals to the Global Consumer Market
BRISTOL, Tenn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Once relegated to the back rooms of hospitals, hypochlorous acid (HOCl) is...
Seres Therapeutics Announces Further Constructive Feedback from FDA on SER-155 Phase 2 Study Protocol and Implements Cost Reduction Actions to Extend Cash Runway
Following recent constructive FDA feedback, Seres anticipates finalizing SER-155 Phase 2 study protocol for the prevention of bloodstream infections in...
Viromed Medical AG initiates approval process for PulmoPlas(R) with the Federal Institute for Drugs and Medical Devices (BfArM)
RELLINGEN, DE / ACCESS Newswire / September 23, 2025 / Viromed Medical AG ("Viromed"; ISIN: DE000A3MQR65), a medical technology company...
Caracal Expands Health Care Portfolio with Launch of Innovative Iodine Product Line in Partnership with I2Pure
DETROIT, Sept. 22, 2025 /PRNewswire/ -- Caracal Products & Services, through its Caracal Healthcare Products division, today announced an expansion of its...
Kane Biotech Completes Enrollment in U.S. Case Series Studies of its revyve® Antimicrobial Wound Gel and Spray
WINNIPEG, Manitoba, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech” or “Kane”) today announces that it...
STAT Marks 10 Years of Reporting from the Frontiers of Health and Medicine
Award-winning journalism has drawn millions of loyal readers BOSTON, Sept. 9, 2025 /PRNewswire/ -- STAT launched 10 years ago with a...
STAT Marks 10 Years of Reporting from the Frontiers of Health and Medicine
Award-winning journalism has drawn millions of loyal readers BOSTON, Sept. 9, 2025 /PRNewswire/ -- STAT launched 10 years ago with a...
Appili Therapeutics to Present Progress on Tularemia Biodefense Vaccine at NATO CBRN Conference
Appili Non-Clinical Director to join NATO and allied representatives and present ATI-1701 biodefense vaccine as a potential solution to the...
Elutia Selected to Exhibit EluPro™ Antibiotic Eluting BioEnvelope at Vizient Innovative Technology Exchange
GAITHERSBURG, Md., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting...
Molecular Designs Launches Urogenital Microbiota Panel to Detect Pathogens and Antibiotic Resistance
Urogenital Microbiota with ABX 53 Simplicity Panel™ delivers same-day research use only results, identifying 28 organisms and 25 resistance markers in...
Biotia and Hospital for Special Surgery Announce Collaboration to Advance Diagnostics for Prosthetic Joint Infections
NEW YORK--(BUSINESS WIRE)--Biotia, a health technology company leveraging next-generation sequencing (NGS) and artificial intelligence (AI), and Hospital for Special Surgery...
Biotia and Hospital for Special Surgery Announce Collaboration to Advance Diagnostics for Prosthetic Joint Infections
NEW YORK--(BUSINESS WIRE)--Biotia, a health technology company leveraging next-generation sequencing (NGS) and artificial intelligence (AI), and Hospital for Special Surgery...
Avails Medical Announces First Commercial Agreement in Company History
MENLO PARK, Calif., Aug. 26, 2025 /PRNewswire/ -- Avails Medical, Inc., a leader in the development of rapid, automated, and...